310 related articles for article (PubMed ID: 21129629)
21. Epidemiology of multidrug resistant bacterial organisms and Clostridium difficile in German hospitals in 2014: Results from a nationwide one-day point prevalence of 329 German hospitals.
Huebner NO; Dittmann K; Henck V; Wegner C; Kramer A;
BMC Infect Dis; 2016 Sep; 16(1):467. PubMed ID: 27590879
[TBL] [Abstract][Full Text] [Related]
22. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.
Baur D; Gladstone BP; Burkert F; Carrara E; Foschi F; Döbele S; Tacconelli E
Lancet Infect Dis; 2017 Sep; 17(9):990-1001. PubMed ID: 28629876
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for the control of glycopeptide-resistant enterococci in hospitals.
Cookson BD; Macrae MB; Barrett SP; Brown DF; Chadwick C; French GL; Hateley P; Hosein IK; Wade JJ;
J Hosp Infect; 2006 Jan; 62(1):6-21. PubMed ID: 16310890
[TBL] [Abstract][Full Text] [Related]
25. Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.
Slayton RB; Toth D; Lee BY; Tanner W; Bartsch SM; Khader K; Wong K; Brown K; McKinnell JA; Ray W; Miller LG; Rubin M; Kim DS; Adler F; Cao C; Avery L; Stone NT; Kallen A; Samore M; Huang SS; Fridkin S; Jernigan JA
MMWR Morb Mortal Wkly Rep; 2015 Aug; 64(30):826-31. PubMed ID: 26247436
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of the epidemiological situation and the resistance phenotype of pathogens isolated from patients in the intensive care unite of the Lodz Medical University Hospital No.1 in 2002-2006].
Bartoszko-Tyczkowska A; Gaszyński W; Tyczkowska-Sieroń E
Med Dosw Mikrobiol; 2008; 60(3):223-30. PubMed ID: 19143176
[TBL] [Abstract][Full Text] [Related]
27. Management of serious nosocomial bacterial infections: do current therapeutic options meet the need?
Lode H
Clin Microbiol Infect; 2005 Oct; 11(10):778-87. PubMed ID: 16153251
[TBL] [Abstract][Full Text] [Related]
28. The changing epidemiology of resistance.
Hawkey PM; Jones AM
J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i3-10. PubMed ID: 19675017
[TBL] [Abstract][Full Text] [Related]
29. [Antimicrobial resistance of methicillin-resistant Staphylococcus aureus in hospital environment and inpatients].
Wu AH; Li CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):525-30. PubMed ID: 19024378
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the link between the management of clinical waste in the National Health Service (NHS) and the risk of the spread of infections: A case study of three hospitals in England.
Tudor TL; Woolridge AC; Phillips CA; Holliday M; Laird K; Bannister S; Edgar J; Rushbrook P
Int J Hyg Environ Health; 2010 Nov; 213(6):432-6. PubMed ID: 20833586
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic consumption as a driver for resistance in Staphylococcus aureus and Escherichia coli within a developing region.
Borg MA; Zarb P; Scicluna EA; Rasslan O; Gür D; Ben Redjeb S; Elnasser Z; Daoud Z
Am J Infect Control; 2010 Apr; 38(3):212-6. PubMed ID: 19900738
[TBL] [Abstract][Full Text] [Related]
32. The epidemiology of antibiotic resistance.
Gould IM
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S2-9. PubMed ID: 18757182
[TBL] [Abstract][Full Text] [Related]
33. Selective digestive tract decontamination--will it prevent infection with multidrug-resistant gram-negative pathogens but still be applicable in institutions where methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci are endemic?
Bonten MJ
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S70-4. PubMed ID: 16894518
[TBL] [Abstract][Full Text] [Related]
34. Strategies for managing today's infections.
Carmeli Y
Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():22-31. PubMed ID: 18318876
[TBL] [Abstract][Full Text] [Related]
35. [Nosocomial infections. Some aspects].
Monteiro JA
Acta Med Port; 1993; 6(3-4):135-40. PubMed ID: 8317232
[TBL] [Abstract][Full Text] [Related]
36. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
Entenza JM; Giddey M; Vouillamoz J; Moreillon P
Int J Antimicrob Agents; 2010 May; 35(5):451-6. PubMed ID: 20185277
[TBL] [Abstract][Full Text] [Related]
37. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.
Carling P; Fung T; Killion A; Terrin N; Barza M
Infect Control Hosp Epidemiol; 2003 Sep; 24(9):699-706. PubMed ID: 14510254
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology meets econometrics: using time-series analysis to observe the impact of bed occupancy rates on the spread of multidrug-resistant bacteria.
Kaier K; Meyer E; Dettenkofer M; Frank U
J Hosp Infect; 2010 Oct; 76(2):108-13. PubMed ID: 20599296
[TBL] [Abstract][Full Text] [Related]
39. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
Shapiro A; Raman S; Johnson M; Piehl M
N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
Huang V; Cheung CM; Kaatz GW; Rybak MJ
Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
